Sobi - North America Revenue and Competitors
Estimated Revenue & Valuation
- Sobi - North America's estimated annual revenue is currently $64.8M per year.
- Sobi - North America's estimated revenue per employee is $155,000
Employee Data
- Sobi - North America has 418 Employees.
- Sobi - North America grew their employee count by 2% last year.
Sobi - North America's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Director, Strategic Pricing and Contracting | Reveal Email/Phone |
2 | National Institutional Senior Director | Reveal Email/Phone |
3 | National Sales Director | Reveal Email/Phone |
Sobi - North America Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Sobi - North America?
Sobi is an international specialty healthcare company dedicated to developing treatments and extensive patient support networks for people with rare and difficult to treat diseases. These patients are often misunderstood, misdiagnosed and have limited medical options otherwise. This commitment has led to our world-class capabilities in protein biochemistry and biologics manufacturing, recognized by our leading industry partners. In North America, we have established our home bases in Waltham, MA and Toronto, Canada. Our employees not only have deep expertise in rare diseases, but are also dedicated to listening and learning from patients, payers and HCPs to ensure we're bringing value to the region in the smartest, most impactful ways. Inflammatory and genetic diseases
keywords:N/AN/A
Total Funding
418
Number of Employees
$64.8M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sobi - North America News
... Incyte Corporation, Jazz pharmaceuticals, Novartis, CytoSorbents, Swedish Orphan Biovitrum (Sobi) ... North America (USA and Canada)
Sanofi can sell it in North America and any remaining markets that Sobi hasn't pursued. North America, of course, includes the U.S. market,...
... immunology and specialty care, Sobi has approximately 1,600 employees across Europe, North America, the Middle East and Asia.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $75.8M | 418 | N/A | N/A |
#2 | $128.5M | 423 | 3% | N/A |
#3 | $63.6M | 424 | -6% | N/A |
#4 | $135.9M | 433 | 4% | N/A |
#5 | $161.3M | 445 | 12% | N/A |